Research News and Research

RSS

California hospitals: Prices rising rapidly, but quality varies

Kaiser Health News writer Jordan Rau, in collaboration with the Bay Area News Group, examines the cost and quality of hospitals in the Bay Area of California.

18 Oct 2010

KHN column: What's the worst that could happen with the new health law?

In this Kaiser Health News column, Rea Hederman and Paul Winfree, both of the Hertiage Foundation, write "the health overhaul could end up costing American taxpayers millions of dollars in higher health insurance premiums or put a tremendous amount of pressure on an already soaring national debt.

18 Oct 2010

Today's Opinions: Health law's effects on the economy and Medicare; 10th Amendment questions

The health care reform legislation also will have a devastating impact on the spending power of working Americans and our economy as the higher premiums kick in (Armstrong Williams, 10/17).

18 Oct 2010

Retroflexion in right colon increases yield of polyps in proximal colon

Research exploring the progression of colon polyps to colorectal cancer and evaluating techniques to improve polyp detection was among the clinical science presented at the 75th Annual Scientific Meeting of the American College of Gastroenterology in San Antonio today.

18 Oct 2010

Sequella to develop SQ109 further with EDCTP, LMU, and TB experts in PanACEA

Sequella, Inc., a clinical-stage company focused on commercializing novel drugs for treatment of life-threatening infectious diseases, announced it has signed an agreement with the Ludwig-Maximilians-University (LMU) of Munich to coordinate a European Union grant for Phase 2 clinical trials of SQ109 in adult pulmonary tuberculosis (TB) in seven sites in Africa.

18 Oct 2010

IBD patients with Vitamin D deficiency at greater risk of osteoporosis, osteopenia

Vitamin D deficiency puts patients with Inflammatory Bowel Disease (IBD) at greater risk of osteoporosis, osteopenia and an overall higher rate of abnormal bone density, according to the results of a new study unveiled today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.

18 Oct 2010

Diversified Agency Services acquires medical communications agency Excerpta Medica

Omnicom Group's Diversified Agency Services (DAS) has acquired Amsterdam-based medical communications agency Excerpta Medica www.excerptamedica.com from world-leading publisher Elsevier, a division of Reed Elsevier Group plc.

18 Oct 2010

Cmed debuts Timaeus 5 unified eClinical platform and Timaeus HotSpot regulatory-compliant eClinical suite

Cmed Technology, an eClinical technology provider, today unveiled two product previews at two major pharmaceutical conferences. It debuted Timaeus 5, Cmed's newest version of its unified eClinical platform to manage data from Study Design through Reporting. Timaeus 5 adds enhanced usability, extended operational capabilities, streamlined investigator and monitor interaction, and expanded reporting capabilities.

18 Oct 2010

Hospital costs rise in California, but quality doesn't follow

News outlets report on rising hospital prices in California and the difficult financial situation of hospitals in New York and Massachusetts.

18 Oct 2010

Long-term care news: Insurance costs jump; nurses' training pays off

The Wall Street Journal: "People with long-term care insurance policies are getting hit with a new round of steep premium increases," which insurers attribute to "policyholders living longer, generating higher claims and canceling fewer policies than they had projected."

18 Oct 2010

Fluticasone gets rid of eosinophils in the esophagus, but does not improve symptoms

A group of Mayo Clinic researchers conducted the first controlled trial of swallowed fluticasone nasal spray (also known as Flonase) on people with the allergic esophageal condition called eosinophilic esophagitis. Research showed that the aerosolized swallowed allergy drug helped treat the cause of the throat condition, but symptoms lingered. The researchers' findings were presented today at the Annual Scientific Meeting of the American College of Gastroenterology in San Antonio.

18 Oct 2010

Beta carotene improves vision in people with Incurable Retinal Disease Retinitis pigmentosa: Report

Today's Scientific Program of the 2010 American Academy of Ophthalmology (AAO) - Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting includes a report on beta carotene's ability to improve vision in people with certain incurable retinal diseases. The AAO-MEACO meeting-the world's largest, most comprehensive ophthalmic education conference-is in session October 16 through 19 at McCormick Place, Chicago.

18 Oct 2010

Fortune 500 CFO launches Apex Healthcare Group

Healthcare is the largest and fastest growing U.S. business sector, with a $2.4 trillion annual spend representing more than 17 percent of national GDP. In this enormous market, provider organizations face unprecedented cost, service and regulatory challenges as a result of the Patient Protection and Affordable Care Act - the national health reform legislation.

18 Oct 2010

Sanofi-aventis and Harvard University enter research collaboration

Sanofi-aventis announced today a research collaboration with Harvard University. The goal of the collaboration is to advance knowledge in the area of human health through basic and applied research and to promote scientific exchange between Harvard University and sanofi-aventis. The focus of this collaboration is translational biomedical research in multiple therapeutic areas such as cancer, diabetes and inflammation.

18 Oct 2010

14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010

Eli Lilly and Company today announced that a total of 14 U.S. and global studies involving its osteoporosis medications, FORTEO® [teriparatide (rDNA origin) injection] and EVISTA® (raloxifene HCl tablets), will be presented at the American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting from October 15-19 in Toronto, ON, Canada.

18 Oct 2010

GeoVax Labs contributes article for HIV vaccine

Robert T. McNally, Ph.D., president and CEO of GeoVax Labs, Inc. a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, has contributed an article on the search for an HIV vaccine to the October 15 issue of Genetic Engineering & Biotechnology News (GEN).

18 Oct 2010

Nanotope enters agreement with Smith & Nephew to develop cartilage regeneration product

Arrowhead Research Corporation today announced that its portfolio company, Nanotope, Inc., has entered into an agreement with Smith & Nephew, Inc., a member of the Smith & Nephew plc group to develop a cartilage regeneration product for human healthcare markets using a subset of its proprietary regenerative medicine technology.

18 Oct 2010

New Trident IWR platform launched at SCDM 2010 Conference

BioClinica, Inc., a leading global provider of clinical trial management services, today announced the launch of its new IVR/IWR (interactive voice response/interactive web response) platform, Trident IWR, at the 2010 Society for Clinical Data Management Annual Conference (SCDM).

From Clario 18 Oct 2010

NanoViricides' President delivers speech at ASNM Second Annual Conference

NanoViricides, Inc. announced today that the Company President was invited to and presented a talk at the Second Annual Conference of the American Society for NanoMedicine (ASNM).

18 Oct 2010

EC grants orphan drug designation to S*BIO's SB1518 for treatment of myelofibrosis

S*BIO Pte Ltd today announced that the European Commission (EC) has granted orphan drug designation to SB1518, its potent and orally active JAK2 inhibitor for the treatment of primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) and post-essential thrombocythemia myelofibrosis (PET-MF). SB1518 has also received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of the same disorder.

18 Oct 2010

Research News and Research

California hospitals: Prices rising rapidly, but quality varies

KHN column: What's the worst that could happen with the new health law?

Today's Opinions: Health law's effects on the economy and Medicare; 10th Amendment questions

Retroflexion in right colon increases yield of polyps in proximal colon

Sequella to develop SQ109 further with EDCTP, LMU, and TB experts in PanACEA

IBD patients with Vitamin D deficiency at greater risk of osteoporosis, osteopenia

Diversified Agency Services acquires medical communications agency Excerpta Medica

Cmed debuts Timaeus 5 unified eClinical platform and Timaeus HotSpot regulatory-compliant eClinical suite

Hospital costs rise in California, but quality doesn't follow

Long-term care news: Insurance costs jump; nurses' training pays off

Fluticasone gets rid of eosinophils in the esophagus, but does not improve symptoms

Beta carotene improves vision in people with Incurable Retinal Disease Retinitis pigmentosa: Report

Fortune 500 CFO launches Apex Healthcare Group

Sanofi-aventis and Harvard University enter research collaboration

14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010

GeoVax Labs contributes article for HIV vaccine

Nanotope enters agreement with Smith & Nephew to develop cartilage regeneration product

New Trident IWR platform launched at SCDM 2010 Conference

NanoViricides' President delivers speech at ASNM Second Annual Conference

EC grants orphan drug designation to S*BIO's SB1518 for treatment of myelofibrosis

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News